ADCT ADC Therapeutics
- 3.630
- -0.190-4.97%
- 3.520
- -0.110-3.03%
ADC Therapeutics News
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Redmile Group, LLC
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Azelby Robert
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BIZZARI JEAN-PIERRE
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hug Peter
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Monges Viviane
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pfisterer Thomas
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sandor Victor
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Squarer Ron
ADC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
ADC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
ADC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
ADC Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Azelby Robert
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BIZZARI JEAN-PIERRE
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hug Peter
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Pfisterer Thomas
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sandor Victor
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Squarer Ron
ADC Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Monges Viviane
ADC Therapeutics | 8-K: Current report
Analysis
Price Target
No Data
